Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women

European Journal of Endocrinology

Volumn 145, Issue 4, 2001, Pages 457-461

  Lasco, A ^a   Frisina, N ^a   Morabito, N ^a   Gaudio, A ^a   Morini, E ^a   Trifiletti, A ^a   Basile, G ^a   Nicita Mauro, V ^a   Cucinotta, D ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRASTERONE; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR RISK; CLAMP; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HEALTH STATUS; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LONG TERM CARE; METABOLIC PARAMETERS; METABOLISM; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 0034811158     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450457     Document Type: Article

References (36)

1. Adrenocortical function in old age: Response to acute adrenocorticotropin stimulation
2. Chrononeuroendocrine markers of the aging brain
3. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
4. Changes in serum concentration of conjugated and unconjugated steroids in 40- to 80-year-old men
5. The relation of smoking, age, relative weight and dietary intake to serum adrenal steroids, sex hormones and sex hormone binding globulin in middle aged men
6. Dehydroepiandrosterone sulfate and aging
7. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men
8. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease
9. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) in Alzheimer's disease and in cerebrovascular dementia
10. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography
11. Total serum cholesterol and urinary dehydroepiandrosterone in humans
12. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women
13. Distribution of dehydroepiandrosterone sulfate and relationships between its level and serum lipid levels in a rural Japanese population
14. Dehydroepiandrosterone replacement in aging humans
15. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding
16. Acute hyperinsulinemia, androgen homeostasis and insulin sensitivity in healthy man
17. Dehydroepiandrosterone: The missing link between hyperinsulinemia and atherosclerosis?
18. Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, non-diabetic, non-smoking normal weight and obese premenopausal women
19. Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate?
20. A close association between insulin resistance and dehydroepiandrosterone sulfate in subjects with essential hypertension
21. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females
22. Dehydroepiandrosterone (DHEA) ameliorates the insulin sensitivity in older rats
23. Enhanced post-receptor insulin effects in women following dehydroepiandrosterone infusion
24. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men
25. Dehydroepiandrosterone in morbidly obese adolescents: Effects on weight, body composition, lipids, and insulin resistance
26. Lack of effect of dehydroepiandrosterone in obese men
27. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life
28. Case report: Amelioration of insulin resistance in diabetes with dehydroepiandrosterone
29. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome
30. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial
31. Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects
32. Glucose clamp technique: A method for quantifying insulin secretion and resistance
33. No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide
34. Estimation of serum low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge
35. Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women